Remove 2017 Remove Independent Pharmacies Remove Prescription Filling
article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

Key Medicare tools to safeguard against pharmacy fraud and inappropriate billing do not apply to Part D. NHC comments to the FTC on PBM business practices and the impact on independent pharmacies and consumers. Prior authorization and association with delayed or discontinued prescription fills. Blendon, R.,

article thumbnail

January 2025 Newsletter

Safe Biologics

Small molecule drugs make up over 90% of prescriptions filled in the U.S. billion in excess revenue from specialty generic drugs between 2017 and 2021, achieving a staggering annual growth rate of 42%. and are essential for treating conditions such as cancer, heart disease, and neurological disorders. Read the FTC Report here.